Substance Use Tools & Resources    

This webinar discusses substance use disorders (SUDs), including Opioid Use Disorder, as a disability and federal disability rights protections for individuals receiving MAT.

This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.

These guidelines provide eligible clinicians who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services.

Provides an example of a progress note for buprenorphine/naloxone maintenance treatment.

This guidance provides recommendations for screening pregnant patients for substance use disorder (SUD) to enhance the well-being of the maternalfetal dyad.

Lists activities that should be performed during followup appointments and behaviors that should be addressed with the patient.

Discusses psychosocial treatment buprenorphine patients should receive.

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.

Provides a sample for buprenorphine treatment intake history and physical.